Cost-effectiveness of universal pneumococcal vaccination for infants in Italy
- 23 May 2005
- Vol. 23 (37), 4565-4576
- https://doi.org/10.1016/j.vaccine.2005.04.033
Abstract
No abstract availableThis publication has 54 references indexed in Scilit:
- Are economic evaluations of vaccines useful to decision-makers? Case study of Haemophilus influenzae type b vaccinesThe Pediatric Infectious Disease Journal, 2004
- Inferring the Potential Success of Pneumococcal Vaccination in Italy: Serotypes and Antibiotic Resistance ofStreptococcus pneumoniaeIsolates from Invasive DiseasesMicrobial Drug Resistance, 2003
- Review of randomized controlled trials on pneumococcal vaccination for prevention of otitis mediaThe Pediatric Infectious Disease Journal, 2003
- Characteristics ofStreptococcus pneumoniaeand Atypical Bacterial Infections in Children 2–5 Years of Age with Community‐Acquired PneumoniaClinical Infectious Diseases, 2002
- Safety and immunogenicity of pneumococcal conjugate vaccine in combination with diphtheria, tetanus toxoid, pertussis and Haemophilus influenzae type b conjugate vaccineThe Pediatric Infectious Disease Journal, 2002
- Clinical Characteristics and Outcome of Patients with Invasive Pneumococcal Disease, Puy-de-Dôme, France, 1994–1998European Journal of Clinical Microbiology & Infectious Diseases, 2001
- Efficacy of a Pneumococcal Conjugate Vaccine against Acute Otitis MediaNew England Journal of Medicine, 2001
- Use of diagnostic clusters to assess the economic consequences of rhinopharyngitis in children in Italy and France during the winterClinical Therapeutics, 1999
- An International Medico-Economic Survey of 2007 Children with Recurrent Nasopharyngitis and Acute Otitis MediaDrugs, 1997
- Recommendations of the Panel on Cost-effectiveness in Health and MedicinePublished by American Medical Association (AMA) ,1996